U.S. FDA approves Merck's new hepatitis C pill By: Reuters: Company News January 28, 2016 at 18:10 PM EST Jan 28 (Reuters) - U.S. regulators on Thursday approved a new once-daily treatment for the liver-destroying hepatitis C virus made by Merck & Co Inc. Read More >> Related Stocks: AbbVie Express Scripts Holding Gilead Sciences Merck & Co